PortfoliosLab logoPortfoliosLab logo
QLYS vs. ZYME
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

QLYS vs. ZYME - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Qualys, Inc. (QLYS) and Zymeworks Inc. (ZYME). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, QLYS achieves a -15.48% return, which is significantly lower than ZYME's -9.30% return.


QLYS

1D
3.52%
1M
9.73%
YTD
-15.48%
6M
-19.23%
1Y
-19.98%
3Y*
-3.38%
5Y*
2.00%
10Y*
14.09%

ZYME

1D
2.67%
1M
-6.76%
YTD
-9.30%
6M
-10.86%
1Y
91.50%
3Y*
43.33%
5Y*
-8.24%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

QLYS vs. ZYME - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
QLYS
Qualys, Inc.
-15.48%-5.22%-28.56%74.89%-18.21%12.60%46.18%11.55%25.93%55.57%
ZYME
Zymeworks Inc.
-9.30%79.85%40.90%32.19%-52.04%-65.32%3.96%209.67%93.33%-43.75%

Correlation

The correlation between QLYS and ZYME is 0.12, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.12

Correlation (3Y)
Calculated over the trailing 3-year period

0.20

Correlation (5Y)
Calculated over the trailing 5-year period

0.19

Correlation (All Time)
Calculated using the full available price history since Apr 28, 2017

0.17

Fundamentals

Market Cap

QLYS:

$4.01B

ZYME:

$1.78B

EPS

QLYS:

$5.57

ZYME:

-$583.41

PS Ratio

QLYS:

5.93

ZYME:

22.95

PB Ratio

QLYS:

7.03

ZYME:

0.01

Total Revenue (TTM)

QLYS:

$684.86M

ZYME:

$78.86M

Gross Profit (TTM)

QLYS:

$569.03M

ZYME:

$77.16M

EBITDA (TTM)

QLYS:

$252.31M

ZYME:

-$47.18B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

QLYS vs. ZYME — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

QLYS
QLYS Risk / Return Rank: 2525
Overall Rank
QLYS Sharpe Ratio Rank: 2323
Sharpe Ratio Rank
QLYS Sortino Ratio Rank: 2323
Sortino Ratio Rank
QLYS Omega Ratio Rank: 2323
Omega Ratio Rank
QLYS Calmar Ratio Rank: 2929
Calmar Ratio Rank
QLYS Martin Ratio Rank: 2626
Martin Ratio Rank

ZYME
ZYME Risk / Return Rank: 8787
Overall Rank
ZYME Sharpe Ratio Rank: 8686
Sharpe Ratio Rank
ZYME Sortino Ratio Rank: 8686
Sortino Ratio Rank
ZYME Omega Ratio Rank: 8484
Omega Ratio Rank
ZYME Calmar Ratio Rank: 9090
Calmar Ratio Rank
ZYME Martin Ratio Rank: 8787
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

QLYS vs. ZYME - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Qualys, Inc. (QLYS) and Zymeworks Inc. (ZYME). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


QLYSZYMEDifference
Sharpe ratioReturn per unit of total volatility

-2.18

Sortino ratioReturn per unit of downside risk

-3.08

Omega ratioGain probability vs. loss probability

0.95

1.33

-0.38

Calmar ratioReturn relative to maximum drawdown

-0.40

4.33

-4.73

Martin ratioReturn relative to average drawdown

-0.81

9.21

-10.02

QLYS vs. ZYME - Sharpe Ratio Comparison

The current QLYS Sharpe Ratio is -0.44, which is lower than the ZYME Sharpe Ratio of 1.74. The chart below compares the historical Sharpe Ratios of QLYS and ZYME, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

QLYS vs. ZYME - Drawdown Comparison

The maximum QLYS drawdown since its inception was -68.48%, smaller than the maximum ZYME drawdown of -91.81%. Use the drawdown chart below to compare losses from any high point for QLYS and ZYME.


Loading charts...

Drawdown Indicators


QLYSZYMEDifference

Max Drawdown

Largest peak-to-trough decline

-68.48%

-91.81%

+23.33%

Max Drawdown (1Y)

Largest decline over 1 year

-50.46%

-21.25%

-29.21%

Max Drawdown (3Y)

Largest decline over 3 years

-62.99%

-45.75%

-17.24%

Max Drawdown (5Y)

Largest decline over 5 years

-62.99%

-87.53%

+24.54%

Max Drawdown (10Y)

Largest decline over 10 years

-62.99%

Current Drawdown

Current decline from peak

-45.44%

-57.97%

+12.53%

Average Drawdown

Average peak-to-trough decline

-20.93%

-52.54%

+31.61%

Ulcer Index

Depth and duration of drawdowns from previous peaks

24.68%

9.97%

+14.71%

Volatility

QLYS vs. ZYME - Volatility Comparison

Qualys, Inc. (QLYS) has a higher volatility of 12.30% compared to Zymeworks Inc. (ZYME) at 10.12%. This indicates that QLYS's price experiences larger fluctuations and is considered to be riskier than ZYME based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


QLYSZYMEDifference

Volatility (1M)

Calculated over the trailing 1-month period

12.30%

10.12%

+2.18%

Volatility (6M)

Calculated over the trailing 6-month period

36.52%

29.45%

+7.07%

Volatility (1Y)

Calculated over the trailing 1-year period

45.62%

52.91%

-7.29%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

39.93%

61.85%

-21.92%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

39.07%

61.45%

-22.38%

Dividends

QLYS vs. ZYME - Dividend Comparison

Neither QLYS nor ZYME has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

QLYS vs. ZYME - Financials Comparison

This section allows you to compare key financial metrics between Qualys, Inc. and Zymeworks Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00100.00M200.00M300.00M400.00M20222023202420252026
175.64M
0
(QLYS) Total Revenue
(ZYME) Total Revenue
Values in USD except per share items

Frequently Asked Questions


QLYS and ZYME have a correlation of 0.12, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

QLYS has higher volatility (12.30%) compared to ZYME (10.12%). In terms of maximum drawdown, QLYS dropped -68.48% vs ZYME's -91.81%.

ZYME currently has the higher Sharpe Ratio (1.74 vs -0.44), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for QLYS and ZYME

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer